Treatment of rheumatoid arthritis with anti-TNF-alpha agents: A reappraisal-Reference-Cited by-同舟云学术

Treatment of rheumatoid arthritis with anti-TNF-alpha agents: A reappraisal

Published:2009-01 Issue:3 Volume:8 Page:274-280
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Caporali Roberto,Pallavicini Francesca Bobbio,Filippini Matteo,Gorla Roberto,Marchesoni Antonio,Favalli Ennio Giulio,Sarzi-Puttini Piercarlo,Atzeni Fabiola,Montecucco Carlomaurizio

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference40 articles.

1. Therapeutic strategies for rheumatoid arthritis;O'Dell;N Engl J Med,2004

2. Cytokine pathways and joint inflammation in rheumatoid arthritis;Choi;N Engl J Med,2001

3. Therapeutic efficacy of multiple intravenous infusions of antitumour necrosis factor alpha monoclonal antibody combined with low dose weekly methotrexate in rheumatoid arthritis;Maini;Arthritis Rheum,1998

4. Molecular mechanisms of TNF-alpha-induced apoptosis in naive and memory T cell subsets;Gupta;Autoimmun Rev,2006

5. ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology;van Gestel;J Rheumatol,1999

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biotechnology Advances in Disease Treatment;International Encyclopedia of Public Health;2025

2. Certolizumab-induced sarcoidosis in a patient with psoriatic arthritis – a case report and review of literature;Rheumatology International;2024-08-24

3. Rheumatoid factor titers, but not Fc fragments, may be strongly associated with drug survival of anti-TNF agents in patients with rheumatoid arthritis;Northern Clinics of Istanbul;2024

4. A Facile Graphene Conductive Polymer Paper Based Biosensor for Dopamine, TNF-α, and IL-6 Detection;Sensors;2023-09-27

5. Inappropriate treatment response to DMARDs: A pathway to difficult-to-treat rheumatoid arthritis;International Immunopharmacology;2023-09